A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Clinical trial NCT05668572 · UNKNOWN

Trial details

NCT number: NCT05668572
Sponsor: Beijing Health Guard Biotechnology, Inc
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2020-12-05
Primary completion: 2022-07-21
Enrollment: 12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.